Jagiello-Gruszfeld, A., Tjulandin, S., Dobrovolsksys, N., Ma-nikhas, A., Pienkowski, T., DeSilvio, M., et al. (2010) A Single-Arm Phase II Trial of First-Line Paclitaxel in Combi-nation with Lapatinib in Her2-Overexpressing Metastatic Breast Cancer. Oncology, 79, 129-135.

紫杉醇脂质体联合顺铂用于转移性或晚期宫颈癌患者一线治疗的近期临床疗效观察及安全性分析
Evaluation Clinical Efficacy and Safety of Paclitaxel Liposome Combined with Cisplatin as First-Line Chemotherapy in the Metastatic or Advanced Cervical Cancer Patients

白引苗, 陈 衍, 孔胜男, 朱文婷, 李新涛, 张红梅    国家自然科学基金支持

临床医学进展Vol.8 No.3, 全文下载: PDF HTML XML DOI:10.12677/ACM.2018.83058, May 21 2018

卡培他滨单药或联合方案治疗转移性乳腺癌临床疗效观察
Clinical Curative Effect Observation of the Treatment of Metastatic Breast Cancer (MBC) with Capecitabine Medicine or Combination Chemotherapy

李 杰, 李凤虎, 常建英, 李杰慧, 袁 佳, 刘诗苑, 冉 立    科研立项经费支持

临床医学进展Vol.4 No.4, 全文下载: PDF HTML DOI:10.12677/ACM.2014.44016, December 31 2014

转移性三阴性乳腺癌临床治疗进展
Clinical Advances in the Treatment of Metastatic Triple Negative Breast Cancer

符 号, 史颖晨, 杨卫卫   

临床医学进展Vol.9 No.7, 全文下载: PDF HTML XML DOI:10.12677/ACM.2019.97134, July 25 2019

白蛋白结合型紫杉醇与SPARC蛋白在乳腺癌中的进展
Progression of Albumin-Bound Paclitaxel and SPARC Protein in Breast Cancer

张 兰, 姜 军   

临床医学进展Vol.11 No.11, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.1111782, November 23 2021

HER2阳性晚期乳腺癌一线治疗的共识和争议
Consensus and Controversy on First-Line Treatment of HER2 Positive Advanced Breast Cancer

梅香萍, 胡 悦, 姚 静   

临床医学进展Vol.14 No.6, 全文下载: PDF HTML XML DOI:10.12677/acm.2024.1461758, June 11 2024

曲妥珠单抗、帕妥珠单抗联合多西他赛对晚期三阳性乳腺癌一线治疗的临床疗效
Clinical Efficacy of Trastuzumab, Pertuzumab and Docetaxel as First-Line Treatment for Metastatic Triple-Positive Breast Cancer

曹 宇, 孙 萍   

临床医学进展Vol.12 No.8, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.1281125, August 23 2022